10-Year-Results of the prospective German-Austrian Phase II Multicenter study for risk-adapted Radiotherapy of localized Prostate Cancer with a moderate Dose Escalation from 70 to 74 Gy

被引：0
作者：
Goldner, G. [1 ]
Bombosch, V. [2 ]
Becker, G. [3 ]
Wachter, S. [4 ]
Glocker, S. [5 ]
Feldmann, H. [6 ]
Bamberg, M. [5 ]
Poetter, R. [2 ]
Molls, M. [7 ]
Geinitz, H. [8 ]
机构：
[1] Med Univ Wien, Klin Strahlentherapie & Biol, Vienna, Austria
[2] Med Univ Wien, Vienna, Austria
[3] Klin Eichert, Goppingen, Germany
[4] Klinikum Passau, Passau, Germany
[5] Univ Klinikum Tubingen, Tubingen, Germany
[6] Stadtklinikum, Fulda, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany
[8] Krankenhaus Barmherzigen Schwestern, Linz, Austria
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 25 条
  • [21] Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study
    De, Brian
    Pasalic, Dario
    Barocas, Daniel A.
    Wallis, Christopher J. D.
    Huang, Li-Ching
    Zhao, Zhiguo
    Koyama, Tatsuki
    Tang, Chad
    Goodman, Michael
    Hamilton, Ann S.
    Wu, Xiao-Cheng
    Paddock, Lisa E.
    Stroup, Antoinette
    Cooperberg, Matthew R.
    Hashibe, Mia
    O'Neil, Brock B.
    Kaplan, Sherrie H.
    Greenfield, Sheldon
    Penson, David F.
    Hoffman, Karen E.
    [J]. JOURNAL OF UROLOGY, 2022, 208 (06) : 1226 - 1239
  • [22] Stereotactic body radiotherapy (SBRT) versus conventional fractionated intensity-modulated radiotherapy (CF-IMRT) for Asian patients with early-stage localized prostate cancer: Acute toxicity results from a prospective randomized phase II study
    Poon, D. M.
    Lam, D.
    Wong, K.
    Mok, F.
    Mo, F.
    Chu, C. M.
    Ng, A. C. F.
    Suen, J.
    Chan, A. T. C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [23] Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study Editorial Comment
    Waters, Michael
    Baumann, Brian C.
    [J]. JOURNAL OF UROLOGY, 2022, 208 (06) : 1238 - 1239
  • [24] Reply to Leonard P. Bokhorst and Berdine L. Heesterman's Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3Randomised, Controlled Trial. Eur Urol. 2022;82:441
    Zapatero, Almudena
    Calvo, Felipe A.
    San-Segundo, Carmen Gonzalez
    Alvarez, Ana
    [J]. EUROPEAN UROLOGY, 2022, 82 (06) : E177 - E178
  • [25] Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study (vol 208, pg 1226, 2022)
    De, Brian
    Pasalic, Dario
    Barocas, Daniel A.
    Wallis, Christopher J. D.
    Huang, Li-Ching
    Zhao, Zhiguo
    Koyama, Tatsuki
    Tang, Chad
    Goodman, Michael
    Hamilton, Ann S.
    Wu, Xiao-Cheng
    Paddock, Lisa E.
    Stroup, Antoinette
    Cooperberg, Matthew R.
    Hashibe, Mia
    O'Neil, Brock B.
    Kaplan, Sherrie H.
    Greenfield, Sheldon
    Penson, David F.
    Hoffman, Karen E.
    [J]. JOURNAL OF UROLOGY, 2023, 209 (02) : 450 - 450
123